Objectives To evaluate the clinical response to cardiac resynchronisation therapy (CRT) in
patients with heart failure and a normal QRS duration (< 120 ms). Setting Single centre …

Despite improved understanding of the pathophysiology of heart failure (HF) and availability
of better medical therapies, HF continues to grow as a cause of morbidity and mortality in A …

Background Cardiac resynchronisation therapy (CRT) can be necessary in patients with
chronic heart failure, who have already been provided with transvenous cardiac implantable …

Cardiac resynchronization therapy (CRT) is an established adjunctive treatment for patients
with systolic heart failure (HF) and ventricular dyssynchrony. The majority of recipients …

Introduction: Cardiac resynchronization therapy (CRT) is now an established
nonpharmacologic therapy for advanced heart failure with electromechanical delay. Despite …

Cardiac resynchronisation therapy (CRT) has been increasingly accepted as an adjunct
therapy to drug treatment for heart failure patients with ventricular conduction delay …

Cardiac resynchronisation therapy (CRT) has emerged as a treatment option for patients
with severe, drug-refractory heart failure and signs of intraventricular dyssynchrony. In …

Over the past 20 plus years, cardiac resynchronization therapy with defibrillation (CRT-D) or
without defibrillation (CRT-P) has become a wellrecognized therapeutic modality for patients …

In the past decade, cardiac resynchronization therapy (CRT), achieved by simultaneous left
and right ventricular pacing, has emerged as a potent therapeutic option for patients with …

Introduction Cardiac resynchronization therapy (CRT) has developed into a very effective
technology for patients with decreased systolic function and has substantially improved …